| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.033 | 0.6 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.035 | 0.6 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.075 | 0.2 |